GLP-1 medications work in several different ways to promote weight loss: 1) by mimicking a naturally occurring GLP-1 hormone in our GI tract, which in turn regulates our insulin and blood sugar levels, 2) by acting in the area of the brain that regulates our hunger cues, and 3) slows stomach emptying which results in feeling fuller for a longer period of time
Multiple large cardiovascular outcome trials with novel glucose-lowering agents like GLP-1 have demonstrated robust and significant reductions in major adverse cardiovascular events and additional cardiovascular outcomes, such as hospitalizations for heart failure in a diabetic population
2024;19:453-478.[DOI] 6
Mechanisms of action The cardiovascular benefits of SGLT2 inhibitors are likely mediated through multiple complementary pathways relevant to heart failure which include osmotic diuresis and natriuresis, which may reduce cardiac preload
The arginine-glycine-aspartic acid (RGD) sequence has been extensively applied in tumor-targeted therapy, mainly targeting v 3 receptors overexpressed on several tumor cells
BPC-157 krijgt vooral aandacht omdat het wordt besproken in relatie tot weefselherstel, mobiliteit en herstel van structuren die normaal gesproken langzaam reageren